StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
EKOP.BR$4.39+0.92%
Fair $4.39+0.0%

EKOP.BR

Ekopak NV

Utilities / Utilities - Regulated WaterBrussels

$4.39

+0.04 (+0.92%)

Fairly Valued+0.0%Fair Value $4.39Fund rank 28/100 · Data gapFallback financials|
SA 11/F
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-19.8M · quality 60.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 44/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

11/100

F

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -32.7%, below the 5% threshold
Thesis & Journal · EKOP.BRLocal privado en este navegador · Ekopak NV
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$77M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-32.7%

↓

Gross Margin

28.0%

↑

Debt/Equity

1.97

↑
52-Week Range$4
$4$8

TradingView lightweight chart

EKOP.BR price, volumen y niveles de valoración

Último $4.390Periodo -70.7%
Fair value: $4.390

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+42.4%

FCF CAGR

—

FCF margin

-38.8%

FCF / Net income

1.43x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $51.1M · net income $-13.8M · FCF $-19.8M

2022-FY → 2025-FY

Gross margin

28.0%+4.1% pts

Operating margin

-26.9%-14.2% pts

Net margin

-27.0%-15.8% pts

FCF margin

-38.8%+41.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$51.1M$51.1M$47.6M$36.0M$17.7M
Net Income$-13.8M$-13.8M$-12.2M$-3.1M$-2.0M
EBITDA$-4.7M$-4.7M$-4.5M$3.3M$-446000.00
EPS-0.79-0.79-0.83-0.21-0.13
Gross Margin28.0%28.0%25.0%35.4%23.9%
Operating Margin-26.9%-26.9%-27.4%-9.4%-12.6%
Net Margin-27.0%-27.0%-25.7%-8.5%-11.2%
Balance Sheet
Debt/Equity1.971.971.880.800.25
Current Ratio0.720.72———
Cash Flow
Free Cash Flow$-19.8M$-19.8M$-31.1M$-12.0M$-14.2M
Returns
ROE-32.7%-32.7%-29.7%-5.7%-3.5%
Valuation
EV/EBITDA———95.29—
P/B1.821.825.185.254.52
Growth & Yield
Revenue Growth7.3%7.3%32.2%103.5%—
EPS Growth4.8%4.8%-295.2%-61.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -35.4%

Total return

-35.4%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.83 → -0.79

Residual

-35.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-35.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.